Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;21(9):1282-7.
doi: 10.1128/CVI.00375-14. Epub 2014 Jul 2.

Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women

Fubao Ma  1 , Longhua Zhang  2 , Renjie Jiang  3 , Jinlin Zhang  4 , Huaqing Wang  5 , Xiaozhi Gao  2 , Xiuhong Li  2 , Yuanbao Liu  4
Affiliations

Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women

Fubao Ma et al. Clin Vaccine Immunol. 2014 Sep.

Abstract

To monitor and evaluate the safety of the influenza A(H1N1) vaccine in pregnant women and its influence on the fetus and neonate, we performed a prospective study in which 122 pregnant Chinese women who received the influenza A(H1N1) vaccine and 104 pregnant women who did not receive any vaccine (serving as controls) were observed. The results indicated that the seroconversion rate in the vaccinated group was 90.4% (95% confidence interval [CI], 82.6% to 95.5%). The rate of adverse events following immunization in the pregnant women who received the influenza A(H1N1) vaccine was 3.3%. The spontaneous abortion rates in the vaccinated group and the unvaccinated group were 0.8% and 1.9%, respectively (exact probability test, P = 0.470), the prolonged-pregnancy rates were 8.2% and 4.8%, respectively (χ(2) = 1.041, P = 0.308), the low-birth-weight rates were 1.6% and 0.95%, respectively (exact probability test, P = 1.000), and the spontaneous-labor rates were 70.5% and 75%, respectively (χ(2) = 0.573, P = 0.449). All newborns who have an Apgar score of ≥7 are considered healthy; Apgar scores of ≥9 were observed in 38.5% and 57.7% of newborns in the vaccinated group and the unvaccinated group, respectively (χ(2) = 8.274, P = 0.004). From these results, we conclude that the influenza A(H1N1) vaccine is safe for pregnant women and has no observed adverse effects on fetal growth. (This study has been registered at ClinicalTrials.gov under registration no. NCT01842997.).

PubMed Disclaimer

Figures

FIG 1
FIG 1
Flow chart of the cohort study on safety of the influenza A(H1N1) vaccine in pregnant Chinese women.
FIG 2
FIG 2
Geometric mean titers (GMTs) and seroconversion before vaccination and 28 days after vaccination.
See this image and copyright information in PMC

References

    1. Anderson BL, Rouse DJ, Fitzsimmons C. 2011. Clinical characteristics of pregnant women with influenza-like illness during the 2009 H1N1 pandemic and use of a standardized management algorithm. Am. J. Obstet. Gynecol. 204(Suppl 1):S31–S37. 10.1016/j.ajog.2011.02.040 - DOI - PMC - PubMed
    1. Robertson LC, Allen SH, Konamme SP, Chestnut J, Wilson P. 2010. The successful use of extra-corporeal membrane oxygenation in the management of a pregnant woman with severe H1N1 2009 influenza complicated by pneumonitis and adult respiratory distress syndrome. Int. J. Obstet. Anesth. 19:443–447. 10.1016/j.ijoa.2010.04.010 - DOI - PMC - PubMed
    1. Bahloul M, Chaari A, Algia NB, Chtara K, Dammak H, Hamida CB, Kallel H, Chelly H, Bouaziz M. 2011. A literature review of respiratory failure following influenza A (H1N1) virus infection in pregnant and postpartum women. Trends Anaesth Crit. Care 1:252–256. 10.1016/j.tacc.2011.08.006 - DOI
    1. Vargas-Parada L. 2009. H1N1: a Mexican perspective. Cell 139:1203–1205. 10.1016/j.cell.2009.12.019 - DOI - PubMed
    1. Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C. 2011. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am. J. Obstet. Gynecol. 204:146.e141–e147. 10.1016/j.ajog.2010.08.050 - DOI - PubMed

Substances

Associated data